Olga K. Parfenova

Olga K. Parfenova

Auto-generated profile, based on publicly available information

Olga K. Parfenova

Department of Research Laboratories, Institute of Biomedical Chemistry (IBMC), 10 Pogodinskaya St, Moscow, 119121, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Russian Medicine
Verified
Journal Article
Open access
PDF file
VKVladimir G. Kukes
Vladimir G. Kukes
OPOlga K. Parfenova
Olga K. Parfenova
NSNikita G. Sidorov
Nikita G. Sidorov
YOYuri V. Olefir
Yuri V. Olefir
AGAlbina А. Gazdanova
Albina А. Gazdanova
This study discusses the role of oxidative stress and inflammation in the development of severe acute respiratory syndrome (SARS) associated with COVID-19 caused by the novel SARS-CoV-2 coronavirus. An analysis of the literature revealed that the development of respiratory viral infections, including COVID-19, is usually accompanied by the accumulation of acidic metabolic products in the blood and tissues and, accordingly, oxidative stress and increased levels of cytokines. In this regard, it seems appropriate to use the second-generation low-toxic antioxidant Ethoxidol, manufactured in Russia, which reduces the intensity of inflammation, and also improves blood oxygen saturation.

1 January 2023 in Человек и его здоровье
Verified
Journal Article
Open access
PDF file
СЕСергей Владимирович Енгашев
Сергей Владимирович Енгашев
ВКВладимир Григорьевич Кукес
Владимир Григорьевич Кукес
APAlexander Poddubikov
Alexander Poddubikov
НСНикита Геннадьевич Сидоров
Никита Геннадьевич Сидоров
АЛАнна Юрьевна Леонова
Анна Юрьевна Леонова
ОДОльга Алексеевна Дорогова
Ольга Алексеевна Дорогова
Objective - to study the effect of three different concentrations of the drug "ASD-2B drops" on the growth of M. tuberculosis strain № 22063. Materials and methods. The effect of three different concentrations of "ASD-2B drops" on the growth of M. tuberculosis strain № 22063 with a single addition of the drug into the reaction mixture was evaluated. Cultivation was carried out in Dubos broth for growing mycobacteria at 37°C for 20 days with periodic assessment of the turbidity index using a densitometer. Results. "ASD-2B drops" at a concentration of 750 µl in 10 ml of the reaction mixture after a single addition at the zero point inhibited the growth and accumulation of biomass of M.tuberculosis strain № 22063 for 10 days compared with the control. "ASD-2B drops" in lower concentrations (37.5 µl and 75 µl) contributed to an increase in the growth and accumulation of biomass of M.tuberculosis strain № 22063 compared with the control. Conclusion. The experiment demonstrated the ability of "ASD-2B drops" with a single addition to influence the growth and accumulation of biomass of M. tuberculosis strain № 22063, depending on the concentration of the drug. The presence of an inducing effect on the M. tuberculosis strain № 22063 provides a basis for further studies of the drug "ASD-2B drops".

1 July 2023 in Current Bioactive Compounds
Verified
Journal Article
Open access
PDF file
VFVladimir A. Furalyov
Vladimir A. Furalyov
VKVladimir G. Kukes
Vladimir G. Kukes
AGAlbina А. Gazdanova
Albina А. Gazdanova
OPOlga K. Parfenova
Olga K. Parfenova
NSNikita G. Sidorov
Nikita G. Sidorov
RKRoman V. Kurkin
Roman V. Kurkin
Background: A cellular model of oxidative stress induced by hydrogen peroxide in the primary culture of myoblasts was obtained by in vitro experiments, and the possibility of exogenous regulation of the cytotoxic effect using 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was studied. Moreover, the influence of oxidative stress and the effect of ethoxidol on the intracellular expression of such an important biomarker as myostatin was investigated. Methods: Hydrogen peroxide was used to induce oxidative stress. The effect of hydrogen peroxide on the rate of myoblast proliferation was studied by measuring the reduction level of (3-(4,5- dimethylthiazole-2-yl))-2,5-diphenyltetrazolium bromide. To measure the expression of myostatin, a real-time polymerase chain reaction (PCR-RV) method was used. Results: During the work, it was clearly demonstrated that hydrogen peroxide has a significant cytostatic effect on myoblasts in vitro, inhibiting their proliferation. Ethoxidol in physiological concentration did not show toxic effects and did not inhibit cell proliferation. This antioxidant revealed a statistically significant protective effect on the cytostatic effect of hydrogen peroxide on myoblasts. In addition, this compound inhibited the expression of myostatin mRNA caused by exposure to hydrogen peroxide as a negative regulator of growth and differentiation of muscle tissue that occurs in response to exposure to reactive oxygen species. Conclusion: Hydrogen peroxide is one of the highly active forms of oxygen and has a significant cytostatic effect on myoblasts in vitro, suppressing their proliferation. 2-ethyl-6-methyl-3- hydroxypyridine malate neutralizes the toxic effect of peroxide, thereby indirectly having a positive effect on the rate of myoblast proliferation in vitro.

19 June 2024 in Electronic Journal of Biotechnology
Verified
Journal Article
Open access
DGDmitry V. Grishin
Dmitry V. Grishin
NSNikita G. Sidorov
Nikita G. Sidorov
OPOlga K. Parfenova
Olga K. Parfenova
RKRoman V. Kurkin
Roman V. Kurkin
EKEkaterina Y. Kasap
Ekaterina Y. Kasap

1 July 2024 in Current Bioactive Compounds
Verified
Journal Article
Closed access
PDF file
VKVladimir G. Kukes
Vladimir G. Kukes
VFVladimir A. Furalyov
Vladimir A. Furalyov
AGAlbina А. Gazdanova
Albina А. Gazdanova
OPOlga K. Parfenova
Olga K. Parfenova
DGDmitry V. Grishin
Dmitry V. Grishin
NSNikita G. Sidorov
Nikita G. Sidorov
Objective: To study the cytotoxic effect of palmitic acid on myoblasts in vitro and the influence of this toxicant on the expression of myostatin mRNA in myoblast culture. Methods: To research the protective action against these processes of a compound with antioxidant activity, for which 2-ethyl-6-methyl-3-hydroxypyridine malate (ethoxidol) was chosen. Results: Our studies have shown that palmitic acid has a noticeable cytostatic effect on myoblasts in vitro, significantly suppressing their proliferation: the rate of MTT recovery in myoblasts treated with palmitate was only 9.6% of that rate in control myoblasts. In experiments, it was shown that palmitic acid slightly activated the expression of myostatin mRNA. At the same time, the protective effect of 2-ethyl-6-methyl-3-hydroxypyridine malate was not so pronounced. Conclusion: The results of our research indicate that the activation of myostatin synthesis is not one of the main causes of the development of myodystrophy in obese people or people following a high-lipid diet, while the direct cytotoxic effect of palmitic acid on myoblasts is. It is obvious that the use of antioxidants such as ethoxide has a protective effect on myoblasts in the experiment and may have a certain potential in clinical practice.

1 November 2021 in Человек и его здоровье
Verified
Journal Article
Open access
PDF file
ВКВладимир Григорьевич Кукес
Владимир Григорьевич Кукес
APAlexey B. Prokofiev
Alexey B. Prokofiev
ОПОльга Константиновна Парфенова
Ольга Константиновна Парфенова
ТАТатьяна Владимировна Александрова
Татьяна Владимировна Александрова
АГАльбина Амырхановна Газданова
Альбина Амырхановна Газданова
АТАлла Аркадьевна Трапкова
Алла Аркадьевна Трапкова
The study and application of representatives of the transforming growth factor-beta (TGF-β) family in practical medicine remains an urgent task at the present time. A more detailed study of the properties and activity of proteins related to TGF-β opens up new possibilities in the treatment and diagnosis of diseases associated with skeletal muscles, female reproductive system, oncology and the cardiovascular system, as well as in the development of drugs based on them. This work examines the role of TGF-β in tumor development and the potential of this protein as a therapeutic target, as well as the signaling pathway, various marker proteins, and various types of receptors involved in this process. During tumor development, TGF-β uses two pathways: the classic SMAD-dependent pathway and the non-SMAD-dependent pathway. In the early stages of tumorigenesis, TGF-β acts as a tumor suppressor, causing a cytostatic effect and apoptosis in normal and pre-malignant cells. However, after tumor development, TGF-β functions as a tumor promoter, triggering the transition of the epithelium to the mesenchyme, which leads to increased invasiveness and the development of metastases. The role of TGF-β in oncogenesis in various organ systems has been studied, including in breast, colon, stomach, hepatocellular carcinoma, thyroid cancer, etc. Specifically, TGF-β1 causes a wide range of different physiological reactions, regulates development, differentiation, carcinogenesis and tumor progression of epithelial cells, has multiple effects on the entire process of hematopoiesis. Directions for the creation of drugs for the treatment of tumors targeting TGF-β are presented.